{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:59:44Z","timestamp":1790729984810,"version":"4.1.0"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n Although primary hyperparathyroidism (PHPT) increases the risk of osteoporotic fractures, estimation of fracture probability among patients with PHPT remains challenging. Use of the Fracture Risk Assessment Tool (FRAX) among these patients remains poorly characterized, and its utility in identifying patients who may experience fracture risk reduction following parathyroidectomy (PTX) remains unknown.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To examine the calibration of FRAX in adults with PHPT and to describe the association between estimated probability and differential fracture risk with PTX compared with nonsurgical management.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This retrospective cohort study was performed from January 1, 2000, to January 1, 2024, using the TriNetX electronic health record US dataset. Participants included adults aged 40 to 90 years with diagnosis or biochemistry findings consistent with PHPT, excluding those with missing or out-of-range FRAX parameters.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n PTX vs nonsurgical management.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Observed major osteoporotic fracture (MOF) and hip fracture. Ten-year FRAX estimations of fracture probability were calculated without bone mineral density (BMD) findings.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Among 59\u202f194 patients with PHPT (mean [SD] age, 65.9 [10.8] years; 44 540 [75.2%] female), 14\u202f783 (25.0%) were treated with PTX. Observed MOF and hip fractures were slightly greater than estimated by FRAX for all deciles of risk, with an MOF calibration y-intercept of 2.0% and slope of 1.17 and hip fracture calibration y-intercept of 1.4% and slope of 1.02. Overall, PTX was associated with a 12% decrease in MOF (hazard ratio [HR], 0.88; 95% CI, 0.77-1.02) and a 13% decrease in hip fracture (HR, 0.87; 95% CI, 0.72-1.07). The MOF score above which PTX was associated with consistently lower MOF hazard was 1.2%, and the corresponding hip score above which PTX was associated with consistently lower hip fracture hazard was 2.7%. Of the cohort not meeting traditional guideline-based surgical criteria, 6522 (25.0%) met this hip score for consistent fracture reduction associated with PTX.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study of US patients with PHPT, FRAX estimation exhibited acceptable performance. FRAX may effectively stratify fracture risk and inform surgical decision-making even in absence of BMD. A larger subset of patients than previously identified by guidelines may benefit from parathyroidectomy from the standpoint of fracture prevention.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.1549","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:30:26Z","timestamp":1773934226000},"page":"e261549","source":"Crossref","is-referenced-by-count":4,"title":["Use and Implications of the Fracture Risk Assessment Tool in Primary Hyperparathyroidism"],"prefix":"10.1001","volume":"9","author":[{"given":"Vivek R.","family":"Sant","sequence":"first","affiliation":[{"name":"Section of Endocrine Surgery, Department of Surgery, UT Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser","family":"ElNakieb","sequence":"additional","affiliation":[{"name":"Clinical Informatics Center, UT Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin F.","family":"Rousseau","sequence":"additional","affiliation":[{"name":"Department of Neurology, UT Southwestern Medical Center, Dallas"},{"name":"Peter O\u2019Donnell Jr. Brain Institute, UT Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Lun","family":"Liu","sequence":"additional","affiliation":[{"name":"Peter O\u2019Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig D.","family":"Rubin","sequence":"additional","affiliation":[{"name":"Division of Geriatric Medicine, Department of Medicine, UT Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naim M.","family":"Maalouf","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Charles and Jane Pak Center for Mineral Metabolism and Clinical Research, UT Southwestern Medical Center, Dallas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"issue":"6","key":"zoi260080r1","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.surg.2013.06.051","article-title":"The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: a population-based analysis from the electronic medical record.","volume":"154","author":"Press","year":"2013","journal-title":"Surgery"},{"issue":"3","key":"zoi260080r2","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2012-4022","article-title":"Incidence and prevalence of primary hyperparathyroidism in a racially mixed population.","volume":"98","author":"Yeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"zoi260080r3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.7326\/0003-4819-126-6-199703150-00003","article-title":"The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992.","volume":"126","author":"Wermers","year":"1997","journal-title":"Ann Intern Med"},{"issue":"8","key":"zoi260080r4","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae096","article-title":"Patient characteristics, management, and outcomes in a novel cohort of primary hyperparathyroidism.","volume":"8","author":"Sant","year":"2024","journal-title":"J Endocr Soc"},{"issue":"3","key":"zoi260080r5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S0895-4356(98)00167-X","article-title":"Fracture risk in the US Medicare population.","volume":"52","author":"Barrett","year":"1999","journal-title":"J Clin Epidemiol"},{"issue":"10","key":"zoi260080r6","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1007\/s00268-018-4629-3","article-title":"Patient frailty should be used to individualize treatment decisions in primary hyperparathyroidism.","volume":"42","author":"Seib","year":"2018","journal-title":"World J Surg"},{"issue":"12","key":"zoi260080r7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.48332","article-title":"Analysis of time to diagnosis and outcomes among adults with primary hyperparathyroidism.","volume":"5","author":"Lorenz","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi260080r8","doi-asserted-by":"publisher","first-page":"2293","DOI":"10.1002\/jbmr.4677","article-title":"Evaluation and management of primary hyperparathyroidism: summary statement and guidelines from the Fifth International Workshop.","volume":"37","author":"Bilezikian","year":"2022","journal-title":"J Bone Miner Res"},{"issue":"11","key":"zoi260080r9","doi-asserted-by":"publisher","first-page":"715","DOI":"10.7326\/M15-1232","article-title":"The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study.","volume":"164","author":"Yeh","year":"2016","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi260080r10","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s00268-008-9720-8","article-title":"Effect of bone mineral density and parathyroidectomy on fracture risk in primary hyperparathyroidism.","volume":"33","author":"VanderWalde","year":"2009","journal-title":"World J Surg"},{"issue":"2","key":"zoi260080r11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1210\/jc.2008-1763","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop.","volume":"94","author":"Bilezikian","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"zoi260080r12","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop.","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"zoi260080r13","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1001\/jamaoncol.2024.4318","article-title":"Fracture risk prediction using the Fracture Risk Assessment Tool in individuals with cancer.","volume":"10","author":"Ye","year":"2024","journal-title":"JAMA Oncol"},{"issue":"3","key":"zoi260080r14","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00198-022-06629-y","article-title":"Primary hyperparathyroidism and fracture probability.","volume":"34","author":"Kanis","year":"2023","journal-title":"Osteoporos Int"},{"issue":"16","key":"zoi260080r15","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.1007\/s11606-023-08347-5","article-title":"Electronic health records (EHRs) can identify patients at high risk of fracture but require substantial race adjustments to currently available fracture risk calculators.","volume":"38","author":"Jain","year":"2023","journal-title":"J Gen Intern Med"},{"issue":"10","key":"zoi260080r16","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1002\/jbmr.3807","article-title":"The design and validation of a new algorithm to identify incident fractures in administrative claims data.","volume":"34","author":"Wright","year":"2019","journal-title":"J Bone Miner Res"},{"issue":"5","key":"zoi260080r17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.bone.2004.06.017","article-title":"A family history of fracture and fracture risk: a meta-analysis.","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone"},{"issue":"3","key":"zoi260080r18","first-page":"141","article-title":"An empirical transition matrix for non-homogeneous Markov chains based on censored observations.","volume":"5","author":"Aalen","year":"1978","journal-title":"Scand J Stat Theory Appl"},{"issue":"1","key":"zoi260080r19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12874-017-0332-6","article-title":"Time-dependent ROC curve analysis in medical research: current methods and applications.","volume":"17","author":"Kamarudin","year":"2017","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"zoi260080r20","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.bone.2009.02.014","article-title":"Bazedoxifene reduces vertebral and clinical fractures in postmenopausal women at high risk assessed with FRAX.","volume":"44","author":"Kanis","year":"2009","journal-title":"Bone"},{"issue":"1","key":"zoi260080r21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s00198-009-1033-8","article-title":"The effects of a FRAX revision for the USA.","volume":"21","author":"Kanis","year":"2010","journal-title":"Osteoporos Int"},{"issue":"1","key":"zoi260080r22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1001\/jamainternmed.2021.6437","article-title":"Risk of fracture among older adults with primary hyperparathyroidism receiving parathyroidectomy vs nonoperative management.","volume":"182","author":"Seib","year":"2022","journal-title":"JAMA Intern Med"},{"key":"zoi260080r23","doi-asserted-by":"publisher","first-page":"S407","DOI":"10.1007\/s00198-010-1253-y","article-title":"Development and use of FRAX in osteoporosis.","volume":"21","author":"Kanis","year":"2010","journal-title":"Osteoporos Int"},{"issue":"3","key":"zoi260080r24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism.","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"issue":"5","key":"zoi260080r25","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/jbmr.1841","article-title":"Primary hyperparathyroidism is associated with abnormal cortical and trabecular microstructure and reduced bone stiffness in postmenopausal women.","volume":"28","author":"Stein","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"17","key":"zoi260080r26","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1056\/NEJM199910213411701","article-title":"A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery.","volume":"341","author":"Silverberg","year":"1999","journal-title":"N Engl J Med"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2846717\/sant_2026_oi_260080_1773348767.01225.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T15:30:27Z","timestamp":1773934227000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2846717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.1549","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]}}}